Clinical Trials Browser

Phase 3 × Endometriosis × relugolix × Clear all

NCT05862272 2025-08-06

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Phase 3 Recruiting

Endometriosis, Leiomyoma, Myofibroma